Wael Elseaidy had a plan for going into business. Then the plan fell apart. While working at Philips, he had expected to take his technology into an arrangement with another company. When that route closed, he faced a less comfortable choice: keep the job, or finance a beginning himself. He chose the beginning, drawing on his retirement savings to help start the company that became Medstreaming.
He later described the decision plainly: It was very stressful back then
. The sentence is a useful antidote to the polished founder biography. A new venture can look admirably inevitable once someone has arranged the dates. At the moment of departure, it still involves leaving a job.
Elseaidy’s career now contains two startup chapters, a continuing partnership, acquisitions, and several changes of corporate name. The interesting thread runs through the transitions. Again and again, his work has concerned how separate parts can be made to function together. That question preceded the chief executive title by years.
Before the business card, the engineering problem
At North Carolina State University, Elseaidy earned a doctorate in civil engineering in 1995. His dissertation examined safety and reliability in real-time engineering systems using formal methods. The title sounds a considerable distance from the language of startup launches. Its subject was concrete: software whose behavior needs to be understood before people depend on it.
That same year, he and John W. Baugh Jr. published a paper on real-time software development. Their work considered how formal models could help establish reliability before deployment. It described a sequence of examining timing requirements, modeling a system, and verifying its behavior through simulation and model checking.
There is something pleasingly inconvenient about this early chapter. It refuses the neat division between the person who understands technology and the person who eventually sells it. Elseaidy’s professional story begins with the workings of software itself. Before the organization chart, there was the question of whether a system would behave as intended.
In 1997, a further paper with Rance Cleaveland and Baugh explored the verification of an active structural control system. It examined design alternatives with demanding timing requirements and showed why analyzing components could help researchers reason about a very large system. The research belongs to a specific engineering problem. It also gives the early career a texture that a list of employers cannot supply: Elseaidy had spent time studying how complex software could be examined, piece by piece.
His engineering career subsequently included GE and Philips. At Philips, his future Medstreaming co-founder Ewald de Vries also worked in software. The partnership would become one of the durable connections in Elseaidy’s business life. Two names would keep turning up, even as the names above the door changed.
- 1995Doctorate at
NC State - 2006Medstreaming
founded - 2016M2S joins
Medstreaming - 2022Astute Imaging
spin-off announced
The work between the systems
Elseaidy and de Vries founded Medstreaming in 2006. By 2011, the company had a geographical reach beyond its Washington base, with additional offices in Chicago, India, and Cairo. A business founded by engineers was already an international operation. Growth, in this case, meant coordinating people as well as building software.
The products carried a recurring proposition: information held in different places should become easier to use together. In 2012, Medstreaming announced web-based analytics for its integrated platform at a conference in Las Vegas. The offering combined records, image management, and practice management, with tools for querying information through the web.
Consider the modest-sounding verb in that proposition: combine. It carries a surprising amount of work. A buyer already has systems, habits, and information. Another application has to find a place among them. Software that looks elegant in a demonstration still has to survive its introduction to everything the customer bought before it.
By February 2014, Medstreaming was presenting a broader data management platform with an expanded analytics module. The design brought imaging and other data into a shared workflow. The company was continuing to pursue the integration problem, adding ways to examine information once it had been assembled.
The everyday challenge is easy to overlook because successful integration can make itself disappear. A user follows a process and reaches the information needed for the next task. The engineering behind that handoff may be extensive, while the desired experience feels almost uneventful. There is an awkward sales problem in this: some of the value consists of work a customer no longer has to notice.
The persistence is more revealing than the product language. Analytics was a feature. Making scattered information usable was the continuing assignment. For a founder with an engineering background, that meant operating in the space where a technical design meets the stubborn arrangements of an existing organization.
Growth comes with other people’s software
In March 2016, Medstreaming announced the acquisition of M2S, a New Hampshire software business. The combined organizations said they would serve more than 1,750 enterprise hospitals and physician practices in the United States and internationally. The transaction expanded the business and brought another established technology organization into its orbit.
The announced plan was to connect Medstreaming’s workflow technology with M2S’s registry applications. Integration was becoming an acquisition strategy as well as a product strategy. The ambition involved joining capabilities that already existed, with customers already using them. Corporate growth arrives with a practical obligation to keep those customers working.
A second 2016 acquisition, Physician Billing Partners, added another business to the group. By 2019, the company was raising outside capital: $22.6 million as part of an equity round. Its leadership combined Elseaidy as chief executive, de Vries as technology chief, and Michael Thompson as chief operating officer.
The sequence gives a more useful view of expansion than a single fundraising number can provide. Products, acquisitions, and financing were occurring within the same company history. Each brought a different operating question. What should be built? What should be brought in? What resources would the enlarged organization need?
A filing records capital, not a personality. Still, the business around that filing helps explain the scope of Elseaidy’s job. He had moved from engineering work to leading an organization with multiple products, acquired businesses, and a continuing need to make the pieces fit.
A new company with a memory
Medstreaming and M2S later became known as Fivos. In February 2022, Fivos announced the spin-off of its imaging services business into Astute Imaging. Elseaidy would lead the new company as chief executive, with de Vries as chief technology officer. The founders were beginning another chapter together.
The separation gave the two businesses distinct areas of focus. For Elseaidy, it also meant returning to a more concentrated venture. Astute would develop its software and services around cloud technology and artificial intelligence. It began with existing technology and business relationships, rather than an empty product folder and a hopeful presentation.
“Our top priority is to maintain business continuity”
Wael Elseaidy · February 2022
The word continuity deserves its place in the announcement. Customers rarely experience a corporate reorganization as an abstract strategic exercise. They experience the next interaction with the business. A founder can be excited about a new company while the customer is primarily interested in tomorrow’s service. Both have legitimate appointments in the diary.
Astute’s next announced move came quickly. In March 2022, it acquired DilenyTech, a startup developing AI technology. DilenyTech founder Ahmed Ehab Mahmoud would join Astute’s founding team and manage imaging operations. The new venture was already extending the team and technical capabilities it had started with.

There is a useful rhythm in those decisions: separate a business to give it focus, then add capabilities through an acquisition. The two moves can coexist. A narrower company still needs people and technology that it does not already possess. Focus describes the assignment; it leaves plenty of work in deciding how to deliver it.
The partnership outlasts the letterhead
In 2024, Elseaidy said much of his team had worked together for more than 15 years. That puts the second venture in a different light. The company was new, but many of the working relationships had already acquired a history. Experience arrived with the people.
His public professional activity continues to show an executive meeting the industry around his business. A 2025 conference program listed him on an artificial intelligence panel. In June 2026, he was promoting conversations at a Boston industry meeting. The work continues through discussions and demonstrations as well as through corporate announcements.
Elseaidy also maintains a public writing presence on LinkedIn. His published articles include discussions of cloud platforms and data sharing from his Medstreaming years, followed by a 2022 article about Astute. Read across their dates, the titles show the subjects he chose to explain while the corporate structure was changing. They provide another thread through the career: the founder describing the technical proposition of the business he was building.
The full arc is unusually resistant to the tidy founder fable. It includes academic research, established employers, a first venture, expansion, and a second venture with familiar colleagues. Progress took several organizational forms. A new company became one way to continue work that had already occupied years.
Elseaidy’s story is most interesting when those years stay in view. The early concern with dependable systems, the recurring effort to connect information, and the partnership with de Vries belong to the same professional life. Starting twice gives that life two launch dates. Much of its substance lies in what happened between them.